» Articles » PMID: 10532420

Expression of the Multidrug-resistance P-glycoprotein (Pgp, MDR-1) by Endothelial Cells of the Neovasculature in Central Nervous System Tumors

Overview
Date 1999 Oct 26
PMID 10532420
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

To elucidate the expression of the MDR1 gene products P-glycoprotein (Pgp) in endothelial cells of newly formed blood microvessels in brain tumors, 30 brain tumors were examined by immunohistochemistry using an anti-Pgp monoclonal antibody, JSB-1. Positive reactions for JSB-1 were detected in endothelial cells in newly formed microvessels in all 16 cases of glioma but not in the 4 meningiomas. Although endothelial cells in newly formed microvessels of all 10 metastatic carcinomas showed positive reactions, negative reactions were seen in those of the primary carcinomas. Compared with reactions of the endothelial cells of normal cerebral capillaries, weak reactions were found in the endothelial cells forming glomeruloid proliferation in newly formed microvessels in the eight glioblastomas and at the border of the surrounding cerebral tissue of the metastatic carcinomas. Since the endothelial cells showing glomeruloid proliferation also had a high proliferative cell nuclear antigen labeling index, the present findings demonstrate a negative relationship between positive reactions for Pgp and the proliferative activities of endothelial cells in cerebral capillaries.

Citing Articles

The impact of ATP-binding cassette transporters in the diseased brain: Context matters.

Baltira C, Aronica E, Elmquist W, Langer O, Loscher W, Sarkaria J Cell Rep Med. 2024; 5(6):101609.

PMID: 38897176 PMC: 11228798. DOI: 10.1016/j.xcrm.2024.101609.


ATP7B expression in human glioblastoma is related to temozolomide resistance.

Moinuddin F, Hirano H, Shinsato Y, Higa N, Arita K, Furukawa T Oncol Lett. 2017; 14(6):7777-7782.

PMID: 29250175 PMC: 5727628. DOI: 10.3892/ol.2017.7249.


Permeability across a novel microfluidic blood-tumor barrier model.

Terrell-Hall T, Ammer A, Griffith J, Lockman P Fluids Barriers CNS. 2017; 14(1):3.

PMID: 28114946 PMC: 5260004. DOI: 10.1186/s12987-017-0050-9.


The blood-brain barrier: an engineering perspective.

Wong A, Ye M, Levy A, Rothstein J, Bergles D, Searson P Front Neuroeng. 2013; 6:7.

PMID: 24009582 PMC: 3757302. DOI: 10.3389/fneng.2013.00007.


Intratumoral modeling of gefitinib pharmacokinetics and pharmacodynamics in an orthotopic mouse model of glioblastoma.

Sharma J, Lv H, Gallo J Cancer Res. 2013; 73(16):5242-52.

PMID: 23796561 PMC: 3755354. DOI: 10.1158/0008-5472.CAN-13-0690.